Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

Developed by ALX Oncology's protein engineers utilizing the Company's proprietary topoisomerase I inhibitor payload and ...

Organoid and organ-on-a-chip technologies represent a transformative leap in the field of biomedical science. Historically, traditional in vitro methods ...

Cuts to funding risk hobbling Boston’s science establishment ...

PDS Biotechnology Corporation (NASDAQ: PDSB) Q1 2025 Earnings Call Transcript May 14, 2025 PDS Biotechnology Corporation ...

A new study published in Aging Cell demonstrates that artificial intelligence can be used not just to accelerate drug ...

Ribonucleic acid, also called RNA, is a molecule present in all living cells. It plays a critical role in transmitting ...

VERSATILE-003 Phase 3 Site Initiations Underway Multiple Abstracts Selected for Presentation at the 2025 American Society of Clinical Oncology Annual Meeting Conference call and webcast today at 8:00 ...

Nabla Bio's latest AI model update generates de novo antibodies for GPCRs with therapeutic-grade properties within a few ...

Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that management will participate in a ...

A novel AI-driven method helps scientists stay ahead of viral evolution by engineering synthetic spike proteins that ...